Annual CFI
$3.51 M
+$549.00 K+18.56%
01 December 2023
Summary:
Artelo Biosciences annual cash flow from investing activities is currently $3.51 million, with the most recent change of +$549.00 thousand (+18.56%) on 01 December 2023. During the last 3 years, it has risen by +$13.54 million (+134.95%). ARTL annual CFI is now at all-time high.ARTL Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$4.25 M
+$2.50 M+142.86%
01 September 2024
Summary:
Artelo Biosciences quarterly cash flow from investing activities is currently $4.25 million, with the most recent change of +$2.50 million (+142.86%) on 01 September 2024. Over the past year, it has increased by +$1.51 million (+55.05%). ARTL quarterly CFI is now at all-time high.ARTL Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$10.01 M
+$6.08 M+154.84%
01 September 2024
Summary:
Artelo Biosciences TTM cash flow from investing activities is currently $10.01 million, with the most recent change of +$6.08 million (+154.84%) on 01 September 2024. Over the past year, it has increased by +$6.50 million (+185.43%). ARTL TTM CFI is now at all-time high.ARTL TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARTL Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +55.0% | +185.4% |
| 3 y3 years | +134.9% | - | - |
| 5 y5 years | +333.7% | - | - |
ARTL Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +134.9% | at high | +238.0% | at high | +186.7% |
| 5 y | 5 years | at high | +134.9% | at high | +147.9% | at high | +181.3% |
| alltime | all time | at high | +134.9% | at high | +147.9% | at high | +181.3% |
Artelo Biosciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.25 M(+142.9%) | $10.01 M(+154.8%) |
| June 2024 | - | $1.75 M(+37.9%) | $3.93 M(+52.4%) |
| Mar 2024 | - | $1.27 M(-53.7%) | $2.58 M(-26.5%) |
| Dec 2023 | $3.51 M(+18.6%) | $2.74 M(-249.6%) | $3.51 M(+36.9%) |
| Sept 2023 | - | -$1.83 M(-559.1%) | $2.56 M(+95.0%) |
| June 2023 | - | $399.00 K(-81.9%) | $1.31 M(-73.2%) |
| Mar 2023 | - | $2.20 M(+22.4%) | $4.90 M(+65.7%) |
| Dec 2022 | $2.96 M(-129.5%) | $1.80 M(-158.3%) | $2.96 M(-138.3%) |
| Sept 2022 | - | -$3.08 M(-177.3%) | -$7.72 M(-4.4%) |
| June 2022 | - | $3.98 M(+1450.6%) | -$8.07 M(-30.1%) |
| Mar 2022 | - | $257.00 K(-102.9%) | -$11.55 M(-6.2%) |
| Dec 2021 | -$10.03 M(+191.7%) | - | - |
| Nov 2021 | - | -$8.88 M(+158.2%) | -$12.32 M(+258.2%) |
| Aug 2021 | -$3.44 M(<-9900.0%) | -$3.44 M(-773.4%) | -$3.44 M(<-9900.0%) |
| May 2021 | - | $510.70 K(-200.0%) | $1200.00(-100.2%) |
| Feb 2021 | - | -$510.70 K(<-9900.0%) | -$509.50 K(<-9900.0%) |
| Nov 2020 | - | $0.00(-100.0%) | $0.00(0.0%) |
| Aug 2020 | $0.00 | $1200.00(>+9900.0%) | $0.00(-100.0%) |
| May 2020 | - | $0.00(-100.0%) | -$1.50 M(-0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Feb 2020 | - | -$1200.00(-99.9%) | -$1.50 M(+0.1%) |
| Aug 2019 | -$1.50 M(>+9900.0%) | -$1.50 M(>+9900.0%) | -$1.50 M(>+9900.0%) |
| May 2019 | - | -$700.00(<-9900.0%) | -$700.00(<-9900.0%) |
| Feb 2019 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Aug 2018 | -$800.00(<-9900.0%) | $0.00(0.0%) | -$900.00(0.0%) |
| May 2018 | - | $0.00(0.0%) | -$900.00(0.0%) |
| Feb 2018 | - | $0.00(-100.0%) | -$900.00(0.0%) |
| Nov 2017 | - | -$900.00(<-9900.0%) | -$900.00(<-9900.0%) |
| Aug 2017 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| May 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Feb 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| May 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Feb 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Aug 2015 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Feb 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Nov 2014 | - | $0.00 | $0.00 |
| Aug 2014 | $0.00 | - | - |
FAQ
- What is Artelo Biosciences annual cash flow from investing activities?
- What is the all time high annual CFI for Artelo Biosciences?
- What is Artelo Biosciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Artelo Biosciences?
- What is Artelo Biosciences quarterly CFI year-on-year change?
- What is Artelo Biosciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Artelo Biosciences?
- What is Artelo Biosciences TTM CFI year-on-year change?
What is Artelo Biosciences annual cash flow from investing activities?
The current annual CFI of ARTL is $3.51 M
What is the all time high annual CFI for Artelo Biosciences?
Artelo Biosciences all-time high annual cash flow from investing activities is $3.51 M
What is Artelo Biosciences quarterly cash flow from investing activities?
The current quarterly CFI of ARTL is $4.25 M
What is the all time high quarterly CFI for Artelo Biosciences?
Artelo Biosciences all-time high quarterly cash flow from investing activities is $4.25 M
What is Artelo Biosciences quarterly CFI year-on-year change?
Over the past year, ARTL quarterly cash flow from investing activities has changed by +$1.51 M (+55.05%)
What is Artelo Biosciences TTM cash flow from investing activities?
The current TTM CFI of ARTL is $10.01 M
What is the all time high TTM CFI for Artelo Biosciences?
Artelo Biosciences all-time high TTM cash flow from investing activities is $10.01 M
What is Artelo Biosciences TTM CFI year-on-year change?
Over the past year, ARTL TTM cash flow from investing activities has changed by +$6.50 M (+185.43%)